Aldeyra Therapeutics Reports First Quarter 2015 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Aldeyra Therapeutics (ALDX) Tops Q1 EPS by 6c
May 13, 2015 7:40 AM EDTAldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
... More